GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Ricamycin® | TMS-19-Q
                                 
                                                         
                            
                            
                            
                                 
                                
                                rokitamycin is an approved drug 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Rokitamycin is a 16-membered semisynthetic macrolide antibacterial compound [3].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| Rokitamycin has improved antibacterial activity against Gram-positive bacteria compared to josamycin and midecamycin [3]. The same study found that it did not have activity against the Gram-negative bacterial strains tested, with the exception of Haemophilus influenzae 1346 (MIC of 6.3-12.5 μg/ml). Rokitamycin also has activity against Borrelia burgdorferi, a spirochaete that causes Lyme disease [2]. |